Related Experiment Video
Updated: Jun 13, 2026
The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
Published on: November 19, 2008
Long-term evaluation of granulocyte-colony stimulating factor on hypoxic-ischemic brain damage in infant rats
Nancy Fathali1, Tim Lekic, John H Zhang
1Department of Human Pathology and Anatomy, Loma Linda University, Loma Linda, CA, USA.
Insights
Granulocyte-colony stimulating factor (G-CSF) treatment improved neurological function and prevented brain damage in neonatal rats after hypoxic-ischemic injury. This suggests G-CSF holds promise for treating fetal brain damage.
Area of Science:
- Neuroscience
- Developmental Biology
- Regenerative Medicine
Background:
- Hypoxia-ischemia (HI) is a significant cause of neonatal brain damage with lasting neurological deficits.
- Effective therapeutic interventions are crucial to mitigate HI's neuropathological and neurofunctional consequences.
Purpose of the Study:
- To evaluate the long-term neuroprotective and functional effects of granulocyte-colony stimulating factor (G-CSF) in a rat model of neonatal cerebral HI.
- To determine if G-CSF treatment can attenuate brain damage and improve neurological outcomes post-HI.
Main Methods:
- Neonatal rats (postnatal day 7) underwent HI surgery (carotid artery ligation followed by 2 hours of hypoxia).
- G-CSF was administered subcutaneously either for 6 or 11 days, starting 1 hour post-hypoxia.
- Neurological deficits, brain morphology, and organ damage were assessed 5 weeks after the HI insult.
Main Results:
- G-CSF treatment significantly improved somatic growth and prevented brain atrophy.
- Both G-CSF dosing regimens enhanced reflexes, limb placing, muscle strength, motor coordination, short-term memory, and exploratory behavior.
- G-CSF also prevented cardiac underdevelopment.
Conclusions:
- G-CSF demonstrates significant long-term neuroprotective effects, both morphologically and functionally, following neonatal hypoxic-ischemic events.
- These findings provide a strong rationale for investigating G-CSF as a clinical therapy for neonatal brain injury.
Purpose:
Hypoxia-ischemia (HI), as a major cause of fetal brain damage, has long-lasting neurological implications. Therefore, therapeutic interventions that attenuate the neuropathological outcome of HI while also improving the neurofunctional outcome are of paramount clinical importance. The aim of this study was to investigate the long-term functional and protective actions of granulocyte-colony stimulating factor (G-CSF) treatment in an experimental model of cerebral HI.
Methods:
Postnatal day-7 Sprague-Dawley rats were subjected to HI surgery, which entailed ligation of the right common carotid artery followed by 2 h of hypoxia (8% O(2)). Treatment consisted of subcutaneous injection of G-CSF at 1 h after hypoxia followed by an additional one injection per day for 5 days (6 total injections) or for 10 days (11 total injections). Animals were euthanized 5 weeks post-insult for extensive evaluation of neurological deficits and assessment of brain, spleen, heart, and liver damage.
Results:
G-CSF treatment promoted somatic growth and prevented brain atrophy and underdevelopment of the heart. Moreover, reflexes, limb placing, muscle strength, motor coordination, short-term memory, and exploratory behavior were all significantly improved by both G-CSF dosing regimens.
Conclusions:
Long-term neuroprotection afforded by G-CSF in both morphological and functional parameters after a hypoxic-ischemic event in the neonate provides a rationale for exploring clinical translation.
